LSD

Bill Gates once revealed that the same person who challenged his intellect as a teenager also pushed him into experimenting with LSD, marijuana and alcohol. This Person's Outsized Influence On Bill Gates' Early Life In "Source Code: My Beginnings," officially released Feb. 4, 2025, Gates looks back...

Billionaire entrepreneur Elon Musk publicly defended himself against allegations of drug use, taking to Twitter to criticize the Wall Street Journal’s reporting. What Happened: Musk, in a post on Sunday, said he had agreed to undertake three years of random drug testing...

Studies and reports from the U.S. Department of Veterans Affairs (VA) and other research publications suggest that an estimated 20-30% of U.S. veterans may experience some form of mental health disorder, with depression and anxiety ranking high amongst conditions.  According the New England...

In a trend that’s raising eyebrows and questions about corporate responsibility, Silicon Valley executives, including Elon Musk and Sergey Brin, are increasingly turning to psychedelics such as ketamine, LSD, and magic mushrooms for business insights and personal growth, The Wall Street...

All manner of pro athletes are coming out with admissions that they smoked weed before or during this or that game, but no one comes close to Pittsburgh Pirates’ Dock Ellis who pitched a no-hitter while tripping on acid. It was on this date in 1970 that Dock Ellis struck out or walked every...

“The Acrobat,” Edward Delaney’s biographical novel based on Cary Grant’s life places a distinct focus on the actor’s use of LSD as part of his psychotherapy at a time when LSD was still legal in the U.S. The famed actor was born Archibald Leach...

According to a scientific study published Wednesday in Nature, a group of computational biologists might have found therapeutic potential in a handful of LSD-adjacent molecules. They generated 3D iterations of more than 75 million related molecules that don’t actually exist but could,...

The market opportunity for legal psychedelics is in the hundreds of billions of dollars, “Shark Tank” judge Kevin O’Leary told the inaugural Benzinga Psychedelics Capital Conference on Tuesday. Investors never get the opportunity to position themselves in a brand new sector,...

Rep. Michael Davis (R) on Wednesday filed a bill to give residents with serious illnesses legal access to a range of psychedelic drugs like psilocybin, ibogaine and LSD through an expanded version of the state’s existing right-to-try law, reported Marijuana Moment. “There is emerging...

MindMed (NASDAQ: MNMD) (NEO: MMED), a clinical-stage biotech company that is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, announced on Dec. 21 that the  Food and Drug Administration (FDA) has placed a clinical hold on its...

Mind Medicine (MindMed) Inc (NASDAQ: MNMD) shares traded higher by 3.3% on Monday after one analyst initiated bullish coverage of the psychedelics stock. The Analyst: Maxim analyst Jason McCarthy initiated coverage of MindMed with a Buy rating and $6 price target. The Thesis: McCarthy...

After receiving Type C Meeting Responses from the FDA, MindMed (NASDAQ: MNMD) has selected Generalized Anxiety Disorder as an initial indication for its Project Lucy, evaluating LSD. The company is on target to formally submit its Investigational New Drug (IND) application for Project Lucy in...

Mind Medicine Inc (NASDAQ: MNMD) was started to address mental wellness, CEO and co-founder J.R. Rahn told Benzinga's Global Small Cap Conference Thursday.  MindMed is discovering and developing new and existing psychedelic molecules as medicines through the FDA pathway,...

Mind Medicine (MindMed) Inc (OTC: MMEDF), a medicine biotech company in psychedelics, on Wednesday announced its start of the first-ever clinical trial measuring and evaluating 3,4-methylenedioxymethamphetamine (MDMA) and lysergic acid diethylamide (LSD) combinations in the human body, at the...